FIG 2.
Time to appropriate therapy in survivors and nonsurvivors, classified by MRSA/VISA categorization. MRVISA, methicillin-resistant vancomycin-intermediate Staphylococcus aureus; VISA, vancomycin-intermediate Staphylococcus aureus.
Time to appropriate therapy in survivors and nonsurvivors, classified by MRSA/VISA categorization. MRVISA, methicillin-resistant vancomycin-intermediate Staphylococcus aureus; VISA, vancomycin-intermediate Staphylococcus aureus.